Clinicians need to ask patients about marijuana as more observational studies are finding a link with marijuana use and cannabis use disorder and cardiovascular outcomes, researchers say.
Less than a month of ticagrelor plus aspirin therapy followed by ticagrelor alone for 1 year after PCI for ACS was noninferior to dual antiplatelet therapy in the T-PASS trial.
No racial or ethnic disparities in long-term adverse effects or cardiovascular mortality were seen among women with obstructive coronary artery disease treated in university or academic centers.
A drug-coated balloon beat conventional balloon angioplasty in treating high-risk patients with in-stent restenosis for outcomes of target lesion restenosis or failure, the AGENT IDE study has shown.
The latest study of statins and diabetes risk points to a small increased risk for new-onset diabetes with rosuvastatin vs atorvastatin, but experts advise caution in interpreting the results.